Meeting
2023 ASCO Genitourinary Cancers Symposium
Developing a novel patient-reported outcome measure for patients with prostate cancer receiving radionuclide therapy: The FACT-RNT.
Authors
Lisa M. Gudenkauf
Moffitt Cancer Center, Tampa, FL
Lisa M. Gudenkauf , Melody Chavez , Melinda Maconi , Carley Geiss , Ameen Seyedroudbari , Pan Thin , Aasha Hoogland , Kathleen Nguyen , Laura B. Oswald , Heather S.L. Jim , Ghassan El-Haddad , Wolfgang Peter Fendler , Ken Herrmann , David Cella , Johannes Czernin , Michael S Hofman , Adam P. Dicker , Jeremie Calais , Scott T. Tagawa , Brian D. Gonzalez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 130)
DOI
10.1200/JCO.2023.41.6_suppl.130
Abstract #
130
Poster Bd #
D14
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Feasibility of SM-88 in PC after multiple prior lines and ECOG < 2 (NCT03512756).
First Author: Marcus Smith Noel
First Author: Karen Basen-Engquist
Poster
2014 ASCO Annual Meeting
Evaluation of an online, skill-building, group intervention for cancer patients and caregivers: Pillars4Life.
First Author: Jonathan David O'Donnell
Poster
2024 ASCO Quality Care Symposium
Elevating the patient voice: Understanding treatment preferences in patients with advanced prostate cancer.
First Author: Elizabeth R. Kessler